Previous Article | Next Article ![]()
Infection and Immunity, July 2005, p. 3896-3902, Vol. 73, No. 7
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.7.3896-3902.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Departments of Medicine,1 Pathology and Laboratory Medicine,2 Dermatology,3 Microbiology and Immunology, Indiana University, Indianapolis, Indiana,6 Department of Pathology, Harvard Medical School,4 Joint Program in Transfusion Medicine, Children's Hospital, Boston, Massachusetts5
Received 15 December 2004/ Returned for modification 9 February 2005/ Accepted 25 February 2005
|
|
|---|
|
|
|---|
In addition to expression of receptors that allow for tissue-specific homing, migratory T cells are also defined as naive, memory, or effector cells by combinations of surface markers, including but not limited to the CD45 isotypes RA and RO, the costimulatory molecule CD27, L-selectin, and chemokine receptors such as CCR7, CXCR3, CXCR4, or CCR5 (9, 17, 29, 30). For example, CD4 populations may be classified as naive (CD45RA+ CD27+ CCR7+), central memory (CD45RA CD27+ CCR7+), and effector memory (CD45RA CD27 CCR7) (9, 29). Similarly, CD8 cells may be defined as naive (CD45RA+ CD27+ CCR7+), central memory (CD45RA CD27+ CCR7+), effector memory (CD45RA CD27 CCR7),and effector (CD45RA+ CD27 CCR7) (12, 13, 29). Functionally, naive and central memory CD4 cells are similar, capable of producing only interleukin-2 (IL-2) upon in vitro stimulation, whereas effector memory populations produce IL-4, IL-5, IFN-
, and some IL-2. Among CD8 T cells, IFN-
and perforin are produced only by the effector memory and effector populations.
Haemophilus ducreyi is an obligate human pathogen and the causative agent of the genital ulcer disease chancroid, which facilitates transmission of human immunodeficiency virus type 1 (4). To study the human immune response to H. ducreyi, we developed an experimental inoculation model with human volunteers (2, 33, 37). In the model, subjects are inoculated at multiple sites on the upper arm with an allergy testing device, which delivers the bacteria to both the epidermis and the dermis. Papules develop at inoculated sites, which evolve into pustules, simulating natural chancroid. The histopathology of experimental infection closely parallels that of naturally occurring disease (22, 25, 26). The lesion consists of a polymorphonuclear leukocyte infiltrate that forms an epidermal abscess and a deep dermal perivascular infiltrate of T cells and macrophages that resembles a poorly formed granuloma that extends interstitially to just below the epidermis (26, 36). By 48 h of infection, T cells make up about 50% of the leukocyte infiltrate and remain abundant throughout the course of experimental infection (20).
Most cutaneous homing studies are performed in the context of noninfectious inflammatory skin diseases (8, 18) or by using CLA+ subsets in peripheral blood as a surrogate system to study cells with skin-homing potential (19, 29, 38). There is a limited amount of information about T cells that home to skin in response to infection (23, 28, 32). Human inoculation experiments with H. ducreyi provide a unique opportunity to study the trafficking and phenotypes of T cells recruited chiefly to the dermis in response to this pathogen (20, 32). Previous work in our laboratory showed that CD4 cells isolated from H. ducreyi-infected pustules are memory cells that are enriched for the skin-homing markers CLA and CCR4. A smaller proportion express the cutaneous marker CCR10, but the CCR10+ cells are not significantly enriched compared to peripheral blood (32). In addition, about half the CD4 T cells in H. ducreyi-infected skin specimens are CD45RA CD27+ CCR7+ central memory cells, but it was not clear whether these cells were enriched relative to peripheral blood (32).
In this study, we further defined the subsets of CD4 T cells present in lesions and for the first time examined the homing and memory/effector phenotypes of CD8 T cells that traffic to infected sites. We also examined longitudinally obtained biopsy specimens for expression of the skin-homing ligands E-selectin and CCL27 and compared them to expression of the lymph node-homing ligands PNAd and CCL21. Taken together with our previous work, these studies allowed us to define the trafficking pathways and phenotypes of T cells recruited in response to experimental H. ducreyi infection in the skin.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Sources of tissue samples
|
Immunohistochemical analysis. Banked sections of paraffin-embedded tissue were stained by immunohistochemistry exactly as described previously (20). Primary antibodies included anti-human E-selectin/CD62E, anti-mouse CCL27, anti-human CLA, anti-human CCL21 (R&D Systems, Minneapolis, MN), and anti-mouse PNAd (MECA-79, BD Pharmingen, San Diego, CA). Biotinylated secondary antibodies (donkey anti-goat immunoglobulin G; Jackson Immunoresearch Laboratories, West Grove, PA) were detected with streptavidin-horseradish peroxidase, followed by 3,3'-diaminobenzidine. Controls included uninfected skin; normal tonsil; omission of the primary antibody for E-selectin, CCL27, and CCL21; and an isotype control for PNAd and CLA. A dermatopathologist analyzed the samples and scored them as positive if at least three separate sections exhibited staining.
Immunophenotyping. Pustules from 17 subjects were biopsied after 5 to 9 days of infection. When multiple sites from one subject were biopsied, the cells were pooled. Biopsy samples were processed as described previously (7, 24). Briefly, 4- to 6-mm punch biopsy specimens were minced in Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco-BRL, Rockville, MD) with 5 mM EDTA (Sigma, St. Louis, MO) and incubated with vigorous stirring for 4 to 6 h at 4°C. Single cells were collected using a 40-µm sieve. Peripheral blood mononuclear cells were isolated from peripheral blood by Ficoll-Hypaque density gradient centrifugation.
Immunostaining was performed with a five-step method as described previously (32). Antibodies used included CD45RA-phycoerythrin (PE)-Texas Red (clone 2H4; Beckman-Coulter, Fullerton, CA), CD27-PE (M-T271; Pharmingen), CD4-allophycocyanin (APC) (SK3; Pharmingen), CD4-APC-cyanine dye 7 (Cy7) (S3.5; CalTag Laboratories, Burlingame, CA), CD8-APC-Cy7 (3B5; CalTag), and CCR7 (150503; R&D Systems). CCR7 was detected with biotinylated goat anti-mouse immunoglobulin G (heavy and light chains; Jackson Immunoresearch Laboratories), followed by streptavidin-PE-Cy7 (Pharmingen). Data were acquired on a dual-laser MoFlo cytometer (Cytomation, Ft. Collins, CO) and analyzed using Summit 3.0 software (Cytomation). Approximately 100,000 peripheral blood CD4 cells, 40,000 peripheral blood CD8 cells, 7,634 ± 5,640 (mean ± standard deviation) lesional CD4 cells, and 3,971 ± 2,636 lesional CD8 cells were analyzed from each subject.
Statistical analysis.
Statistical analysis was performed with pairwise comparisons. Using the Bonferroni adjustment to account for multiple comparisons, P values of <0.017 or
0.013 were considered significant when three or four groups were analyzed, respectively.
|
|
|---|
![]() View larger version (122K): [in a new window] |
FIG. 1. Immunohistochemical staining of skin biopsy samples. A, C, E, and G are uninfected samples. B, D, F, and H are infected samples. A and B were probed with anti-E-selectin. C and D were probed with anti-PNAd. E and F were probed with anti-CCL27. G and H were probed with anti-CCL21. Original magnification, x400. Arrows in panels B, C, D, and H point to positive staining (brown). Arrows in panels A and G point to blood vessels that do not react with the antibody. Blue color is hematoxylin, a counterstain used to show structure.
|
|
View this table: [in a new window] |
TABLE 2. Expression of selectins and chemokines in infected skin
|
![]() View larger version (143K): [in a new window] |
FIG. 2. Cutaneous lymphocyte antigen expression in skin biopsy specimens using immunohistochemistry. A is a normal skin sample. B, C, and D are pustules. Magnifications: A and B, x100; C and D, x400. Brown color is CLA-positive staining. Blue color is hematoxylin, a counterstain used to show structure.
|
CCL21, a chemokine expressed by endothelial cells in the lymph nodes, small intestine, and spleen, allows for trafficking of CCR7+ T cells to lymphoid tissues. Because it is a potent T-cell chemoattractant and we had previously found CCR7+ cells in infected skin (32), we examined H. ducreyi-infected skin for expression of CCL21. Endothelium in uninfected skin did not react with anti-CCL21 antibody (Fig. 1G). In all but one sample infected with live H. ducreyi, CCL21 was expressed by endothelial cells in the dermis (Fig. 1H and Table 2). In addition to endothelial cell staining, occasional mononuclear cells in the perivascular infiltrate expressed CCL21. Thus, CCL21 was upregulated during infection but not expressed in uninfected skin.
Expression of memory/effector markers by CD4 cells in infected skin. Previously, we examined the skin-homing phenotypes of the CD4 T-cell infiltrate in three pustules using the markers CD45RA, CLA, CCR7, CCR4, and CCR10 (32). Those experiments showed that the CD4+ T cells in infected sites are predominantly CD45RA CLA+ CCR4+. A subset of the CCR4+ cells are also CCR10+. To better define the T-cell populations recruited to the skin, we analyzed pustules from 15 subjects. We initially examined expression of CD45RA and CD27 on CD4 cells. Lesional cells were compared to each subject's peripheral blood cells at the time of biopsy. Approximately 55% of the skin CD4 cells were CD45RA CD27+ cells and 40% were CD45RA CD27 cells, while <5% were CD45RA+ CD27+ (Fig. 3A). The CD45RA CD27 population was significantly enriched relative to donor-matched peripheral blood cells (P < 0.0001).
![]() View larger version (17K): [in a new window] |
FIG. 3. Flow cytometry analysis of naive and memory/effector CD4 T cells in lesions. Open bars, CD4 cells isolated from donor-matched peripheral blood. Solid bars, CD4 cells isolated from infected skin. Mean ± standard deviation is shown. A, n = 15 subjects; B, n = 3 subjects. Asterisks denote statistical differences from peripheral blood. A P value of <0.017 was considered significant in panel A. A P value of 0.013 was considered significant in panel B. Note that the bars in panel A represent all CD4 T cells, whereas the bars in panel B express the percentage of memory/effector cells (CD45RA).
|
Expression of memory/effector and skin-homing markers by CD8 cells in infected skin.
We isolated CD8 T-cell populations from infected skin from 11 subjects and compared them to CD8 cells in donor-matched peripheral blood. We initially examined expression of CD45RA and CD27 and found that there were significantly fewer CD45RA+ CD27+ CD8 cells in the skin relative to peripheral blood (
20% versus
50%, P < 0.0001) (Fig. 4A). The proportion of CD45RA CD27+ and CD45RA+ CD27 cells in the skin was not significantly different than in peripheral blood, but the cutaneous CD8 cells were significantly enriched in CD45RA CD27 cells relative to blood (40% versus 10%, P = 0.0006) (Fig. 4A).
![]() View larger version (18K): [in a new window] |
FIG. 4. Flow cytometry analysis of naive and memory/effector CD8 T cells in lesions. Open bars, CD8 cells isolated from donor-matched peripheral blood. Solid bars, CD8 cells isolated from infected skin. Mean ± standard deviation is shown. A, n = 11 subjects; B, n = 3 subjects. Asterisks denote statistically significant differences from peripheral blood. A P value of <0.013 was considered significant. Note that the bars in panel A represent all CD8 T cells, whereas the bars in panel B express the percentage of memory/effector cells (CD45RA).
|
|
|
|---|
The use of multiple markers such as CD45RA, CD27, and CCR7 in flow cytometry is predictive of the functional subsets of T cells (10). Because the relationship between these markers and function is well established and due to limited cell numbers obtained from infected sites, we did not confirm function by intracellular cytokine staining. Using expression of CD45RA and CD27, we determined that the CD4 population in skin was primarily composed of memory and effector cells, and the latter cells were significantly enriched relative to peripheral blood. The majority of CD4+ CD27+ memory cells also expressed CCR7, a marker of central memory cells (28). Our findings are similar to those on erythema migrans, in which CD4 cells that migrate to infected skin consist predominantly of central memory cells and effector memory cells. The CD8 cells isolated from H. ducreyi-infected skin were significantly enriched in memory effector cells and depleted in naive cells relative to peripheral blood. These findings are also similar to those on erythema migrans, except that central memory CD8 cells are enriched in erythema migrans relative to peripheral blood (28).
In the human challenge model, papules develop at virtually all sites inoculated with estimated delivered doses in the range of 1 to 120 CFU (33). These papules either spontaneously resolve or evolve into pustules. There are host and gender effects on the outcomes for the sites (5, 34). Men are 2.8-fold (95% confidence interval, 1.6- to 5.1-fold) more likely than women to develop pustules (5) (data not shown). Experimental infection with H. ducreyi to the pustular stage does not confer protection against subsequent challenge (1). Subjects who initially are classified as resolvers or pustule formers and who are rechallenged tend to repetitively resolve infection at all sites or repetitively form pustules (34). In pustules, H. ducreyi is surrounded by polymorphonuclear leukocytes and macrophages, which fail to ingest the organism (3). However, there is no correlation in the ability of phagocytes isolated from resolvers and pustule formers to ingest the organism in vitro and clinical outcome (34). These data suggest that the overall composition of the lesion modulates the ability of phagocytes to clear the bacteria. The CD4 cells recovered from pustules in this study had memory or effector phenotypes, consistent with our ability to isolate H. ducreyi-specific CD4 T-cell lines from pustules (15). Interestingly, some of these lines have characteristics of regulatory T cells, which could promote phagocytic failure (34). The significance of the recruitment of memory effector CD8 cells to a site of an extracellular bacterial infection is unclear.
In H. ducreyi-infected skin, the majority of infiltrating T cells were CLA+ and there was upregulation of E-selectin on dermal endothelial cells. These data are consistent with earlier studies on CLA expression by skin-homing T cells (27) and by T cells recruited to sites of inflammation such as atopic dermatitis, contact dermatitis, psoriasis, and delayed-type hypersensitivity reactions (31, 32). Similarly, Koelle's group recently showed that antigen-specific CD8+ T cells specific for skin-tropic viruses (herpes simplex virus type 2 [HSV-2]) are CLA+ while CD8+ cells specific for non-skin-tropic viruses (Epstein-Barr virus and cytomegalovirus) are CLA (23). A greater proportion of HSV-specific CD8 cells recovered from lesions express CLA relative to HSV-specific CD8 cells recovered from peripheral blood, and E-selectin is upregulated in HSV-2-infected tissue (23). E-selectin was initially thought to bind to the CLA epitope on T cells, but recent evidence emphasizes the role of fucosyltransferase VII and E-selectin binding ligands other than CLA as initial steps in the transmigration of T cells from blood vessels into skin (38-40). Nevertheless, CLA is a useful marker for expression of these E-selectin binding ligands.
By immunohistochemistry, CCL27 was expressed at similar levels in both uninfected and infected skin. In a previous study, we showed that about 10% of CD4 T cells in chancroidal lesions and in a delayed-type hypersensitivity response to dermal injection of Candida antigens express CCR10, the receptor for CCL27 (32). These data contrast with findings on psoriasis and atopic or allergic contact dermatitis, in which CCL27 expression is increased relative to normal skin and the majority of skin-infiltrating lymphocytes express CCR10 (18). The small percentage of cells expressing CCR10 and the lack of upregulation of CCL27 due to infection indicate that this ligand-receptor pair is not a major factor in T-cell homing in response to H. ducreyi. In experimental H. ducreyi infection and in delayed-type hypersensitivity responses, the bacteria and antigens are delivered primarily to the dermis and most of the T cells infiltrate the deep region of the dermis. In contrast, in psoriasis and contact dermatitis, most of the T cells infiltrate the upper dermis and epidermis. We speculate that CCL27 and CCR10 play a major role in trafficking of T cells to sites of epidermal inflammation rather than deep dermal inflammation.
The receptor-ligand pair CCR7-CCL21 is crucial for entry of T cells into lymphoid tissue but until recently has not been associated with trafficking to skin. CCR7 and CCL21 are also important in the emigration of Langerhans cells from skin to lymph nodes (14). We found that CCL21 was expressed in the dermal endothelium of infected skin but not in healthy skin. Similar results were found by Hromas and colleagues for atopic dermatitis, lichen planus, and graft-versus-host disease (8). In that study, CD45RO and CCR7 were expressed on T cells that infiltrated diseased skin, as demonstrated by immunohistopathology (8). While these data suggest that the CCL21-CCR7 pathway is operative in cutaneous T-cell homing, the number of CCR7-expressing cells in the skin was not compared to that in peripheral blood. Our data show quantitatively that there is no enrichment of CCR7+ CD4 or CD8 central memory or effector memory cells in infected skin relative to peripheral blood. Thus, CCR7+ cells are not precluded from entering the skin in response to H. ducreyi, but it is unlikely that the CCR7-CCL21 pathway plays a major role in selective enrichment of memory T cells. CCL21 may play a role in the migration of Langerhans cells out of skin and into draining lymph nodes.
Taking our present results together with those of our previous studies (32), we can propose a model outlining the receptor and ligand pairs that likely are most involved in homing of T cells to the dermis of H. ducreyi-infected skin. An initial loose association occurs between E-selectin on the endothelial cells and CLA+ T cells. The predominance of CCR4+ cells in lesions (32) suggests that CCR4-CCL17 mediates a subsequent interaction that allows migration of CCR4+ cells into the tissue. Unfortunately, our attempts to stain for CCL17 in tissue were technically unsuccessful. Although CCL21 is upregulated at infected sites, there is no enrichment of lesional CCR7+ cells relative to populations present in peripheral blood, and CCR7-CCL21 likely does not play a major role in T-cell recruitment. Similarly, the presence of CCL27 in both uninfected skin and infected skin, along with a minority population of CCR10+ cells in lesions, indicates that CCR10-CCL27 has a lesser role in trafficking of T cells in this model.
The combinations of PNAd-L-selectin and CCR7-CCL21 are known to be critical for trafficking of naive T cells to lymphoid tissue (29). Although CCR7- and CCL21-expressing cells were found in the skin, there was minimal expression of PNAd in normal and diseased skin. The fact that few naive T cells accumulated in the lesions emphasizes the importance of the combined role of PNAd-L-selectin and CCR7-CCL21 in homing of naive T cells to lymphoid tissue.
In summary, we determined that T cells that traffic to the dermis of H. ducreyi-infected skin likely utilize the CLA-E-selectin and CCR4-CCL17 pathways, while the CCR7-CCL21 and CCR10-CCL27 pathways play minor roles in this process. Our data indicate that the T cells that home to skin infected with H. ducreyi are predominantly central and effector memory cells, with an enrichment of effector memory cells relative to T cells present in peripheral blood. Studies to determine the effect that these T cells have on outcome in the model are ongoing in our laboratory.
We thank Barry Katz for statistical analyses; Margaret Bauer for thoughtful criticism of the manuscript; Kate Fortney, Stacy Bennett, Marti Greenwald, and Beth Zwickl for assistance with the human challenge trials; and the volunteers who participated in the study.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»